A
Ann E. Clarke
Researcher at University of Calgary
Publications - 461
Citations - 27641
Ann E. Clarke is an academic researcher from University of Calgary. The author has contributed to research in topics: Population & Lupus erythematosus. The author has an hindex of 71, co-authored 417 publications receiving 22908 citations. Previous affiliations of Ann E. Clarke include McGill University & University College London.
Papers
More filters
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.
John M. Esdaile,Michal Abrahamowicz,Tamara Grodzicky,Yin Li,Constantina Panaritis,Roxane du Berger,Robert Côté,Steven A. Grover,Paul R. Fortin,Ann E. Clarke,Jean-Luc Senécal +10 more
TL;DR: There is a substantial and statistically significant increase in CHD and stroke in SLE that cannot be fully explained by traditional Framingham risk factors alone.
Journal ArticleDOI
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer,Karen H. Costenbader,David I. Daikh,Ralph Brinks,Marta Mosca,Rosalind Ramsey-Goldman,Josef S Smolen,David Wofsy,Dimitrios T. Boumpas,Diane L. Kamen,David Jayne,Ricard Cervera,Nathalie Costedoat-Chalumeau,Betty Diamond,Dafna D. Gladman,Bevra H. Hahn,Falk Hiepe,Søren Jacobsen,Dinesh Khanna,Kirsten Lerstrøm,Elena Massarotti,Joseph M. McCune,Guillermo Ruiz-Irastorza,Jorge Sanchez-Guerrero,Matthias Schneider,Murray B. Urowitz,George Bertsias,Bimba F. Hoyer,Nicolai Leuchten,Chiara Tani,Sara K. Tedeschi,Zahi Touma,Gabriela Schmajuk,Branimir Anić,Florence Assan,Tak Mao Chan,Ann E. Clarke,Mary K. Crow,László Czirják,Andrea Doria,Winfried Graninger,Bernadett Halda-Kiss,Sarfaraz Hasni,Peter M. Izmirly,Michelle Jung,Gábor Kumánovics,Xavier Mariette,Ivan Padjen,José M. Pego-Reigosa,Juanita Romero-Diaz,Íñigo Rúa-Figueroa Fernández,Raphaèle Seror,Georg Stummvoll,Yoshiya Tanaka,Maria G Tektonidou,Carlos Vasconcelos,Edward M Vital,Daniel J. Wallace,Sule Yavuz,Pier Luigi Meroni,Marvin J. Fritzler,Ray Naden,Thomas Dörner,Sindhu R. Johnson +63 more
TL;DR: To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism and the American College of Rheumatology (ACR).
Journal ArticleDOI
Mortality in systemic lupus erythematosus.
Sasha Bernatsky,J. F. Boivin,Lawrence Joseph,S. Manzi,Ellen M. Ginzler,Dafna D. Gladman,Murray B. Urowitz,Paul R. Fortin,M. Petri,Susan G. Barr,Caroline Gordon,Sang Cheol Bae,David A. Isenberg,Asad Zoma,Cynthia Aranow,Mary Anne Dooley,Ola Nived,Gunnar Sturfelt,Kristjan Steinsson,Graciela S. Alarcón,J L Senécal,Michel Zummer,John G. Hanly,Stephanie Ensworth,Janet E. Pope,Steven M. Edworthy,Anisur Rahman,J Sibley,Hani El-Gabalawy,Timothy McCarthy,Y. St. Pierre,Ann E. Clarke,Rosalind Ramsey-Goldman +32 more
TL;DR: The Lupus Survival Study Group data are reviewed and particularly the data from the State University of New York Health Science Center at Brooklyn, NY is reviewed.
Journal ArticleDOI
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
Mark Crowther,Jeffrey S. Ginsberg,Jim A. Julian,Judah A. Denburg,Jack Hirsh,James D. Douketis,Carl A. Laskin,Paul R. Fortin,David C. Anderson,Clive Kearon,Ann E. Clarke,William Geerts,Melissa A. Forgie,David Green,Lorrie Costantini,Wendy Yacura,Sarah E. Wilson,Michael Gent,Michael J. Kovacs +18 more
TL;DR: The low rate of recurrent thrombosis among patients in whom the target INR was 2.0 to 3.0 suggests that moderate-intensity warfarin is appropriate for patients with the antiphospholipid antibody syndrome.